isomethyleugenol has been researched along with Cholangiitis, Sclerosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, AH; Juran, BD; Lazaridis, KN; Moore, RM; Punia, S; Schlicht, EM; Sun, Z | 1 |
| Ahrendt, SA; Chow, JT; Eisenberger, CF; Pitt, HA; Rashid, A; Sidransky, D; Yip, L | 1 |
2 other study(ies) available for isomethyleugenol and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.
Topics: Biomarkers; Cell-Free Nucleic Acids; Cholangitis, Sclerosing; Humans; Liver; Liver Cirrhosis, Biliary; Methylation; Pilot Projects | 2021 |
Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Topics: Adult; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chick Embryo; Cholangiocarcinoma; Cholangitis, Sclerosing; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; Female; Gene Deletion; Gene Expression Regulation; Genes, p16; Humans; Immunohistochemistry; Male; Methylation; Microsatellite Repeats; Middle Aged; Promoter Regions, Genetic | 1999 |